Charles River Associates publishes CRA Insights, a newsletter highlighting recent thinking and announcements from members of our Life Sciences Practice.
Beyond the single asset: The rise of combination and synergistic innovation in neurology drug development
Introduction Historically, drug development within the neurology space has been characterized by the search for individual therapies that can arrest complex...